# Bridgenebiosciences

**Canonical:** https://apis.io/providers/bridgenebiosciences/  
**Website:** https://equityzen.com/company/bridgenebiosciences  
**APIs profiled:** 0

BridGene Biosciences is a biotechnology company focused on pioneering the next era of small molecule therapeutics. The company develops innovative platforms to discover and optimize novel drug candidates, aiming to address unmet medical needs across various disease areas.

## Kin Score — 3.0 / 100 (minimal)

Scored 2026-10-09 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Bridgenebiosciences Domain Security** — TLSv1.3 · DMARC

## Tags

Biotechnology, Drug Discovery, Small Molecules, Therapeutics, Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/bridgenebiosciences/). Scores are computed from the provider's own public artifacts under a published rubric.